Jesse Veenstra

Dr. Jesse Veenstra

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ATA. Tisack
A. Tisack
AFA. Fotouhi
A. Fotouhi
CFC. Fidai
C. Fidai
BFB.J. Friedman
B.J. Friedman
DODavid Matthew Ozog
David Matthew Ozog
JVJesse Veenstra
Jesse Veenstra

24 August 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
LZLi Zhou
Li Zhou
AJAimin Jiang
Aimin Jiang
JVJesse Veenstra
Jesse Veenstra
DODavid Matthew Ozog
David Matthew Ozog
QMQing-Sheng Mi
Qing-Sheng Mi
Langerhans cells (LC) are a unique population of tissue-resident macrophages with dendritic cell (DC) functionality that form a network of cells across the epidermis of the skin. Their location at the skin barrier suggests an important role for LC as immune sentinels at the skin surface. The classification of LC as DC over the past few decades has driven the scientific community to extensively study how LC function as DC-like cells that prime T cell immunity. However, LC are a unique type of tissue-resident macrophages, and recent evidence also supports an immunoregulatory role of LC at steady state and during specific inflammatory conditions, highlighting the impact of cutaneous environment in shaping LC functionality. In this mini review, we discuss the recent literature on the immune tolerance function of LC in homeostasis and disease conditions, including malignant transformation and progression; as well as LC functional plasticity for adaption to microenvironmental cues and the potential connection between LC population heterogeneity and functional diversity. Future investigation into the molecular mechanisms that LC use to integrate different microenvironment cues and adapt immunological responses for controlling LC functional plasticity is needed for future breakthroughs in tumor immunology, vaccine development, and treatments for inflammatory skin diseases.

1 April 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JVJesse Veenstra
Jesse Veenstra
PDPeter Dimitrion
Peter Dimitrion
YYYi Yao
Yi Yao
LZLi Zhou
Li Zhou
DODavid Matthew Ozog
David Matthew Ozog
QMQing-Sheng Mi
Qing-Sheng Mi

5 July 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JVJesse Veenstra
Jesse Veenstra
DODavid Matthew Ozog
David Matthew Ozog
ILIan Loveless
Ian Loveless
IAIndra Adrianto
Indra Adrianto
PDPeter Dimitrion
Peter Dimitrion
QMQing-Sheng Mi
Qing-Sheng Mi


3 May 2024 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JVJesse Veenstra
Jesse Veenstra
DODavid Ozog
David Ozog